Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues LFST Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency EQX Q1 2026 Earnings Marginal EPS Miss as Stock Declines PEBK Q4 2025 Earnings Solid EPS of 121 Stock Declines on Limited Guidance THM Q1 2026 Earnings Modest Profit Reported Amid No Revenue and Market Pullback Oceaneering International OII Slips 067 as Stock Tests Key Support Zone Abits Group ABTS Holds Steady Near Support as Consolidation Takes Hold ChipMOS Technologies IMOS Gains Momentum A Strong Session Above Key Support Roivant Sciences ROIV Slides Support Levels in Focus After 298 Decline NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline